Why Regeneron Pharmaceuticals Inc (NASDAQ: REGN) is a biotech force to be reckoned with
Regeneron was founded in 1988 by Dr. Leonard S Schleifer. Dr. Schelifer shared, that the name Regeneron came from “Regenerating neurons, with the word “gene” in the middle”. The origin of the name further explains that the initial focus of the company was neurobiology. Then in 1990 following the publication